Jiazhou Ye

Negative regulation of MAVS-mediated innate immune response by ASC

Feixiang Wu, Xiang He, Congwen Wei, 2017, Molecular and Cellular Biochemistry.

TACE combined Lenvatinib plus Camrelizumab versus TACE alone in efficacy and safety for unresectable hepatocellular carcinoma: a propensity score-matching study

Jie Chen, Xiaobo Wang, Lequn Li, 2024, BMC cancer.